Your browser doesn't support javascript.
loading
Potential Risks Related to Modulating Interleukin-13 and Interleukin-4 Signalling: A Systematic Review.
Braddock, Martin; Hanania, Nicola A; Sharafkhaneh, Amir; Colice, Gene; Carlsson, Mats.
Affiliation
  • Braddock M; Global Medicines Development, AstraZeneca, Granta Park, Great Abington, Cambridge, CB21 6GH, UK. martin.braddock@astrazeneca.com.
  • Hanania NA; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, 6620 Main Street, Houston, TX, 77030, USA.
  • Sharafkhaneh A; Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, 6620 Main Street, Houston, TX, 77030, USA.
  • Colice G; Medical Care Line, Michael E. DeBakey VA Medical Center, 2002 Holcombe Boulevard, Houston, TX, 77030, USA.
  • Carlsson M; Global Medicines Development, AstraZeneca, One MedImmune Way, Gaithersburg, MD, 20878, USA.
Drug Saf ; 41(5): 489-509, 2018 05.
Article in En | MEDLINE | ID: mdl-29411337
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Interleukin-4 / Interleukin-13 Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Animals / Humans Language: En Journal: Drug Saf Journal subject: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Year: 2018 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Interleukin-4 / Interleukin-13 Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Animals / Humans Language: En Journal: Drug Saf Journal subject: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Year: 2018 Type: Article Affiliation country: United kingdom